5-Year Survival Data of Durvalumab after Chemoradiotherapy for unresectable Stage III NSCLC - an Update from the PACIFIC Study
Author
Lee, K. H.
Kato, T.
Macpherson, E.
Newton, M.
Thiyagarajah, P.
Antonia, S.
Reck, M.
de Wit, M.
Spigel, D.
Faivre-Finn, C.
Gray, J.
Vicente, D.
Planchard, D.
Paz-Ares, L.
Vansteenkiste, J.
Garassino, M.
Hui, R.
Quantin, X.
Rimner, A.
Wu, Y. -L.
ÖZGÜROĞLU, Mustafa
Metadata
Show full item recordCollections
- Makale [92796]